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Non-viral generation of neural precursor-like cells from adult human fibroblasts
Abstract
Recent studies have reported direct reprogramming of human fibroblasts to mature neurons by the
introduction of defined neural genes. This technology has potential use in the areas of neurological
disease modeling and drug development. However, use of induced neurons for large-scale drug screening
and cell-based replacement strategies is limited due to their inability to expand once reprogrammed. We
propose it would be more desirable to induce expandable neural precursor cells directly from human
fibroblasts. To date several pluripotent and neural transcription factors have been shown to be capable of
converting mouse fibroblasts to neural stem/precursor-like cells when delivered by viral vectors. Here we
extend these findings and demonstrate that transient ectopic insertion of the transcription factors SOX2
and PAX6 to adult human fibroblasts through use of non-viral plasmid transfection or protein transduction
allows the generation of induced neural precursor (iNP) colonies expressing a range of neural stem and
pro-neural genes. Upon differentiation, iNP cells give rise to neurons exhibiting typical neuronal
morphologies and expressing multiple neuronal markers including tyrosine hydroxylase and GAD65/67.
Importantly, iNP-derived neurons demonstrate electrophysiological properties of functionally mature
neurons with the capacity to generate action potentials. In addition, iNP cells are capable of
differentiating into glial fibrillary acidic protein (GFAP)-expressing astrocytes. This study represents a
novel virus-free approach for direct reprogramming of human fibroblasts to a neural precursor fate.
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Non-Viral Generation of Neural Precursor-like
Cells from Adult Human Fibroblasts
Maucksch C1, Firmin E1, Butler-Munro C2, Montgomery JM2, Dottori M3, Connor B1
Recent studies have reported direct reprogramming of human fibroblasts to mature neurons by the introduction of
defined neural genes. This technology has potential use in the areas of neurological disease modeling and drug
development. However, use of induced neurons for large-scale drug screening and cell-based replacement
strategies is limited due to their inability to expand once reprogrammed. We propose it would be more desirable
to induce expandable neural precursor cells directly from human fibroblasts. To date several pluripotent and
neural transcription factors have been shown to be capable of converting mouse fibroblasts to neural
stem/precursor-like cells when delivered by viral vectors. Here we extend these findings and demonstrate that
transient ectopic insertion of the transcription factors SOX2 and PAX6 to adult human fibroblasts through use of
non-viral plasmid transfection or protein transduction allows the generation of induced neural precursor (iNP)
colonies expressing a range of neural stem and pro-neural genes. Upon differentiation, iNP cells give rise to
neurons exhibiting typical neuronal morphologies and expressing multiple neuronal markers including tyrosine
hydroxylase and GAD65/67. Importantly, iNP-derived neurons demonstrate electrophysiological properties of
functionally mature neurons with the capacity to generate action potentials. In addition, iNP cells are capable of
differentiating into glial fibrillary acidic protein (GFAP)-expressing astrocytes. This study represents a novel virusfree approach for direct reprogramming of human fibroblasts to a neural precursor fate.
Key Words: Adult human fibroblast cells, induced neural precursor cells, PAX6, somatic cell reprogramming, SOX2
Introduction
Cellular differentiation and lineage commitment have
traditionally been considered as robust and irreversible
processes. Recent work however has demonstrated that
mature somatic cells can be reprogrammed to a pluripotent
embryonic stem cell-like state by forced expression of the
stem cell associated genes OCT3/4, SOX2, KLF4 and/or C[1-3]
Using this technology, a range of cell types have
MYC.
[2,4,5]
been reprogrammed including human fibroblast cells,
[6]
[7]
keratinocytes, mesenchymal cells, peripheral blood cells
[8]
[9]
and adipose stem cells. [10] In addition, it
, melanocytes
has been demonstrated that forced expression of lineagespecific transcription factors can convert fibroblasts directly
to blood progenitor cells, [11] mature cardiomyocytes, [12]
[13]
[14-18]
hepatocyte-like cells , neural stem/precursor-like cells
[19-24]
and mature neurons
without first reverting to an
intermediate pluripotent state. As such, somatic cell
reprogramming provides a unique platform by which to
dissect the molecular mechanisms that underlie epigenetic
reprogramming and lineage specification as well as the
exciting opportunity to personalize human cells for both
research and clinical application.

Several studies have reported direct reprogramming of
human fibroblast cells to mature neurons by the introduction

of defined neural genes.[19-24] Further, neuronal cell subtypes
[24]
or dopaminergic
such as functional spinal motor neurons
[20,22]
neurons
have been generated by over-expression of
specific transcription factor combinations. Cell culture systems
utilizing induced mature neurons have potential in the areas of
neurological disease modeling and drug development. However,
a clear limitation of postmitotic induced neurons is their inability
to expand once reprogrammed. To date expandable neural
stem/precursor-like cells have only been generated from mouse
fibroblasts by viral transduction of pluripotent and neural
[14-18]
We therefore investigated whether
transcription factors.
adult human fibroblasts could be directly reprogrammed to
become neural precursor cells through ectopic expression of
specific neural transcription factors using non-viral technologies.

Different combinations of up to seven pluripotent and neural
transcription factors have been identified to be capable of
converting mouse fibroblasts into neural stem/precursor-like
cells.[14-18] However, current knowledge regarding the key
factors required to initiate neural stem/precursor fate
determination in mouse and particularly in human cells is very
limited. We hypothesized that genes which are involved in
directing the differentiation of embryonic stem cells to the
neuroectoderm lineage may also serve to reprogram human
fibroblasts towards a neural stem/precursor-like state. Based on
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previous work, [25,26] we identified the neural genes SOX2
and PAX6 as playing a key role in the early stages of
neurogenesis. SOX2 is a key factor in reprogramming cells to
[2,5]
and is also associated with multipotent
a pluripotent state
[27-29]
PAX6 is essential for neural
and unipotent stem cells.
stem cell proliferation, multipotency and neurogenesis.[30]
SOX2 and PAX6 are also expressed when embryonic stem
[25,27-32]
cells undergo differentiation to a neural lineage.
Further, we have previously observed that neural induction of
human embryonic stem cells results in mutually exclusive
[25]
expression of PAX6 and the pluripotency factor OCT3/4,
indicating the involvement of PAX6 in neural lineage
determination.

The current study provides proof-of-concept that transient
expression of SOX2 and PAX6 in adult human fibroblasts
generates induced neural precursor-like (iNP) colonies
expressing a range of neural stem and precursor genes, and
immature neural markers. Upon differentiation, iNP colonies
give rise either to mature neurons capable of generating
action potentials upon current injection or to astrocytes as
indicated by GFAP expression. This was achieved using
either non-viral plasmid transfection or recombinant protein
transduction technology alleviating concerns of insertional
mutation associated with the use of genome-integrating viral
vectors. Furthermore, we have optimized cell culture
conditions allowing us to generate iNP colonies in the
absence of an animal or human feeder cell layer, an
essential requirement for the transfer of reprogrammed cell
lines to clinical use. This technology provides a novel and
ethically viable option for obtaining neural precursor cells for
neurological research and clinical application.

plasmid DNA amount of 2µg. pCMV-SPORT6 comprising
PAX6 cDNA was purchased from Invitrogen. SOX2 cDNA
was purchased from Addgene and cloned into pEGFP-N1
(Clontech) after removal of eGFP expression cassette from
pEGFP-N1. Protein co-transductions were carried out in four
transduction cycles using a mix of SOX2-TAT protein
(PeproTech) and PAX6 protein (Abnova) or PE control
protein (OzBioscience) with ProDeliverIn (OzBioscience) in a
ratio 1:1 and a total protein amount of 5µg per transduction
cycle.

Quantitative RT- PCR
3
Total RNA was isolated from 2.5 – 9.0 x 10 colonies of four
independent iNP cell lines and two independent control cell
lines by RNAeasy Mini Kit (Invitrogen), respectively. cDNA
was synthesised from total RNA using Superscript reverse
transcriptase (Invitrogen). Three independent duplex qPCR
reactions were performed in triplicates for each independent
cell line using the TaqMan system (Applied Biosystems) with
ribosomal 18S rRNA as the internal standard and an
equivalent of 4ng mRNA per reaction.

Immunocytochemistry
Immunocytochemical staining was carried out by standard
procedures using the following human-specific primary
antibodies: CD133 (Abcam), SOX2 (R&D Systems), PAX6
(Covance), NGN2 (R&D Systems), MASH1 (Chemicon),
TUJ-1 (Covance), NSE (DAKO), MAP2 (Chemicon), GAD65/67
(Chemicon), TH (Chemicon), and GFAP (DAKO).

Differentiation of iNP cells.

Materials & Methods
Cell culture
Human dermal fibroblast cells (HDF) isolated from the
abdomen of two adult donors were obtained from Cell
Applications Inc. and maintained in human HDF Growth
Media (Cell Applications, Inc.). Plasmid DNA transfections
and protein transduction were performed at passage 8 or
earlier. Media was changed to proliferation medium
comprising Neurobasal-A (Gibco), 1% D-glucose (SigmaAldrich), 1% Penicillin/Streptomycin/Glutamine (Gibco), 2%
B27 supplement (Gibco), 0.2% EGF (PeproTech), 0.08%
FGF-2 (PeproTech), 0.2% Heparin (Sigma-Aldrich) and VPA
(Sigma-Aldrich) to a concentration of 1µM three days posttransfection or post-transduction. Media was changed threetimes weekly, and cells were replated regularly during iNP
colony formation.

Induced neural precursor colonies were generated by
SOX2/PAX6 plasmid transfection and cultured for 6 weeks in
neural precursor proliferation media medium comprising of
NBA
media,
2%
B27,
1%
D-glucose,
1%
Penicillin/Streptomycin/Glutamine, 0.2% EGF, 0.08% FGF-2,
0.2% Heparin, 1µM VPA and 25ng/ml Midkine (Peprotech).
For neuronal differentiation, the cells were mechanically
dissociated and transferred onto poly-ornithine/laminincoated (Sigma-Aldrich/ Invitrogen) surface following full
colony formation and differentiated using a two-step protocol
as previously described.[33] Briefly, cells were cultured in NBA
media supplemented with 250ng/ml SHH (R&D systems),
100ng/ml DKK1 (PeproTech), 20ng/ml BDNF (PeproTech)
and 10μM Y27632 (Calbiochem). After 10 days, culture
conditions were changed to NBA media containing 0.5mM
dibutryl-cyclic AMP (Sigma-Aldrich), 0.5μM VPA, 20ng/ml
BDNF and 10μM Y27632.

Transcription factor delivery
HDF cells at 1 × 105 cells per well were seeded in
polystyrene 6-well plates (Nunc - Thermo Fisher Scientific)
24 hrs prior to transfection or transduction. Media was
changed to Optimem (Invitrogen) 2 hrs prior to the
transfection procedure. Nonviral plasmid transfections were
carried out using Lipofectamin LTX, Plus reagent (Invitrogen)
and plasmid constructs encoding SOX2 , PAX6 or eGFP
driven by a CMV promoter at a ratio 3:1:1 (v/v/w) and a total

For glial differentiation iNP colonies were mechanically
dissociated following full colony formation and plated onto on
fibronectin-coated surface. Astroglial differentiation was
carried out in Glasgow minimum media (Sigma-Aldrich),
supplemented
with
10%
FBS
and
1%
Penicillin/Streptomycin/Glutamine for 14 days. To promote
oligodendroglial differentiation, cells were cultured in 3
stages: NBA media supplemented with 2% B27, 1% Dglucose, 1% Penicillin / Streptomycin / Glutamine, 0.08%
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FGF-2 and 0.1% retinoic acid (Sigma-Aldrich) for 2 days,
followed by DMEM/F12 media containing 0.5% N2
supplement (Invitrogen), 10ng/mL FGF-2, 10ng/mL PDGF,
0.5mM dibutryl-cyclic AMP for 4 days and DMEM/F12,
30ng/mL 3,3',5-Triiodothyronine (Sigma-Aldrich), and 200µM
Ascorbic acid (Sigma-Aldrich) for an additional 4 days.
Electrophysiology
Whole cell patch clamping was performed as previously
described [34] on iNP–derived neurons after 13, 21 and 30
days of differentiation. Briefly, cells were bathed in artificial
cerebrospinal fluid (in mM: 120 NaCl, 3 KCl, 2 CaCl2, 1.25
NaH2PO4, 2 MgSO4, 20 glucose, 26 NaHCO3). Internal
solution consisted of (in mM: 120 K gluconate, 40 HEPES, 5
MgCl2, 2 NaATP, 0.3 NaGTP). Cells were visualised on an
Olympus BX51W1. Electrode resistance was 5 MΩ. Action
potentials were induced in current clamp mode by a 10 ms
current injection using a Multiclamp 700B Commander
(Molecular Devices). Series resistance was constantly
monitored and results were not included if significant
variation (>20%) occurred during an experiment. Data
acquisition and analysis was performed using pClamp9
software.
Results
SOX2 and PAX6 convert human fibroblasts to neural
precursor-like cells.
SOX2 and PAX6 are key transcription factors in the
development and maintenance of neural precursor cell
identity. We therefore investigated the potential of ectopic
SOX2 and PAX6 expression to directly convert adult human

fibroblasts to neural precursor-like cells. A homogenous
population of adult human dermal fibroblasts previously used
to induce pluripotency by Yamanaka and colleagues, and
shown to be free of cell cross-contamination was used in this
study.[2,35] Protein transduction and non-viral plasmid
transfection systems were utilized to provide transient ectopic
expression of SOX2 and PAX6 in adult human fibroblasts
(Figure 1A). Optimization of transfection / transduction
efficiencies and control experiments were performed using
either an eGFP plasmid or red-fluorescent phycoerythrin (PE)
protein, respectively (Figures 1B, 1C).

Neural differentiation protocols for human embryonic stem
(hES) cells suggested the use of defined neural culture
conditions in the absence of a mouse embryonic fibroblast
(MEF) feeder layer to drive differentiation towards a
neuroectodermal fate.[36,37] Thus, fibroblasts were allowed to
recover in human fibroblast growth media for 3 days after
SOX2/PAX6 delivery before being transferred to specific
neural precursor cell culture conditions consisting of
Neurobasal A media (NBA) with B27 supplement, FGF2,
EGF and valproic acid (VPA). For both SOX2/PAX6 plasmid
transfection and protein transduction, we observed significant
changes in fibroblast density and morphology between days
5 to 10 following transfer to neural precursor cell culture
conditions. The changes occurred in a temporal order with
decreasing cell density, altered morphology to a more
compact shape and grouping of cells (Figure 2A). Strikingly,
we observed the formation of domed and compact
neurosphere-like cell colonies 4 weeks after protein delivery
and 8 to 11 weeks after ectopic gene expression of SOX2

Figure 1: Timeline of protein / plasmid DNA delivery and generation of iNP cell colonies. (A) Transcription factors were introduced into fibroblast cells by either plasmid
DNA transfection or protein transduction. Plasmid DNA transfections were carried out in human dermal fibroblast growth media using Lipofectamin LTX with a lipoplex
incubation time of 24 hrs. Cells were subsequently cultured in human dermal fibroblast growth media for another 3 days before culture conditions were changed to NBA
media to allow colony formation within 35-60 days. Protein transduction was performed in four cycles over a period of 12 days using ProDeliverin. Transductions were
performed for 48 hrs in human dermal fibroblast growth media. Cells were cultured in human dermal fibroblast growth media for additional 24 hrs after transduction
procedure. Transductions were carried out in four cycles of 72hrs each. (B) Phycoerythrin protein was utilised to optimize and assessed ProDeliverIn mediated protein
transduction into human dermal fibroblast cells. FACS analysis revealed a protein transduction efficiency of 54%. (C) Nonviral plasmid transfection was optimized to an
efficiency of 12% using pCMV-EGFP-N1 plasmid and Lipofectamine LTX. Scale bars: 100µm
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and PAX6. Colonies induced by plasmid transfection and
protein transduction both appeared with a regular, round
morphology with a diameter between 50 - 500μm (Figure
2B). Interestingly, fibroblasts transfected with eGFP control
plasmid or transduced with PE control protein and cultured in
neural culture conditions for up to 11 weeks occasionally
developed cell colony structures (Figure 2C). However,
colony formation in control cultures occurred significantly
later, with lower efficiency and a less uniform morphology
than SOX2/PAX6-induced colonies. In contrast, fibroblasts
cultured in human fibroblast growth media only grew in a
monolayer and showed no colony formation at any time point
(Figure 2D).
To investigate the proliferative capability of induced cell
colonies, primary colonies were mechanically dissociated
and replated as single cells. Within 2-3 days, individual cells
generated secondary colonies with increased cell diameter
(Figure 2E). Repeated dissociation and replating gave rise to
tertiary and quaternary colonies. Formation and growth of
uniform colonies could be increased and accelerated by

and PAX6 expression exhibited features of neural precursor
cells, we investigated the transcriptional signature and
phenotypic characteristics of SOX2/PAX6 induced colonies
compared to eGFP or PE controls. Total RNA from three fully
developed independent colony lines was isolated at 65, 75 or
85 days respectively following plasmid transfection, and an
additional colony line was isolated 27 days following protein
transduction. A range of neural stem cell and precursor
genes and positional markers within the neuroectodermal
tube were analyzed and compared by quantitative PCR
(Figure 3A). We observed that colonies transduced with
SOX2 and PAX6 protein exhibited SOX2 and PAX6 mRNA
expression in contrast to the PE control (Figure 3A). Due to
the transient nature of protein transduction in contrast to
delivery of genetic material, this observation strongly
indicates the activation of endogenous SOX2 and PAX6
mRNA expression by ectopic protein transduction. Similar to
protein transduction, SOX2 and PAX6 mRNA expression
levels were found in independent SOX2/PAX6 induced
colony lines formed at different time points after transient

Figure 2: Generation of induced neural precursor colonies from human fibroblasts. (A) Temporal change of fibroblast morphology from 1 - 5 weeks following
SOX2/PAX6 delivery (wfd). (B) Fully developed iNP colonies 6 weeks after SOX2/PAX6 delivery. (C) Fibroblast morphology 11 weeks after either eGFP plasmid
transfection (TF) or PE protein transduction (TD). (D) Untreated fibroblasts maintained their morphology when cultured in human dermal fibroblast growth media.
(E) Secondary iNP colonies reformed within 3 days following mechanical dissociation. Scale bars: 100 µm.

regular replating of cells to an efficiency of 0.05% of the
number of fibroblasts initially transfected/transduced with
SOX2/PAX6. Regular cell replating also decreased the time
required for full colony formation to 5 - 8 weeks following
plasmid transfection.
These results demonstrate that transient ectopic delivery of
SOX2 and PAX6 can direct the generation of uniform
induced colonies resembling neural precursor cell
neurosphere colony formation.[38,39] Furthermore, colony
formation was achieved in the absence of a MEF feeder cell
layer.
Induced
colonies
characteristics.

show

neural

precursor-like

plasmid DNA transfection with the highest relative expression
observed in colony lines isolated 65 days after transfection
and gradually decreasing in colony lines isolated 75 and 85
days post transfection (Figure 3A). Quantitative PCR analysis
further demonstrated elevated mRNA expression levels of
the neural markers neurogenin2 (NGN2), SOX1, HOXB9,
NKX6.1 and SIX3. eGFP- and PE-treated controls showed
either no mRNA expression or relatively lower levels of these
markers (Figure 3A). In contrast, HES1 and IRX3 mRNA
levels were reduced in iNP colonies generated by
SOX2/PAX6 protein transduction compared to PE control
cells (Figure 3A). Transcriptional profile determination of
three independent colony lines generated by plasmid
transfection revealed

To assess if cell colonies induced by transient ectopic SOX2
P165
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Figure 3: Characterization of induced neural precursor cells. (A) Gene expression profiles of independent iNP colony lines generated by protein
transduction (TD) or plasmid transfection (TF) at different time points post transcription factor delivery compared to eGFP transfection (eGFP), PE
transduction (PE) and hESC-derived neural precursor cell (hNP) controls. Heatmap represents the average cycle threshold values normalized to internal
ribosomal 18S rRNA control (∆Ct) obtained from three independent qPCR reactions, respectively. (B) Expression of SOX2, PAX6 and NGN2 in iNP colonies.
Scale bars: 25 µm.

a distinctive pattern of neural gene expression dependent on
the duration following delivery of SOX2/PAX6 (Figure 3A).
Colony lines analyzed 65 days following SOX2/PAX6 delivery
exhibited elevated mRNA expression levels of SOX2, PAX6,
SOX1, HOXB9, NKX6.1 and reduced HES1 and IRX3
expression relative to eGFP controls. Conversely, colony
lines analyzed at 85 days showed a shift towards higher
HES1, IRX3, SIX3 and lower PAX6, SOX2, NGN2 and SOX1
expression levels compared to the colony lines analysed 65
days post SOX2/PAX6 treatment. In accordance, colony lines
examined 75 days following SOX2/PAX6 treatment displayed
intermediate transcription factor expression levels. This
suggests a progressive transition of neural gene expression
towards a more mature phenotype over time following the
initial induction of SOX2 and PAX6 expression. The gene
expression pattern of the iNP colony lines was also
compared to noggin-primed hES-derived neural precursor
(hNP) cells (Figure 3A). Quantitative PCR analysis
demonstrated higher mRNA expression levels of SOX2,
PAX6, SOX1 and NGN2 in hNP cells compared to iNP cells.
This may reflect either the presence of partially
reprogrammed iNP cells or a population of nonreprogrammed fibroblasts present in the culture.
It has been shown that the putative pluripotent marker
OCT3/4 is expressed in neural stem cells and that
expression of NANOG is partially regulated by a SOX2OCT3/4 complex.[40-42] Thus, we assessed if expression of
SOX2 in iNP colonies is associated with the expression of
OCT3/4 and/or NANOG. OCT3/4 mRNA levels were found to
be up-regulated in iNP colony lines isolated 65 days after

plasmid transfection and in colony lines generated by protein
transduction when compared to controls. However, analysis
of iNP colony lines isolated 75 days following SOX2/PAX6
gene delivery revealed no increase in OCT3/4 expression
(Figure 3A). Similar results were found for NANOG, with an
increase in NANOG mRNA expression only observed in iNP
colony lines isolated at 65 or 75 days post transfection and in
protein-treated colony lines when compared to controls
(Figure 3A).
To further assess the expression of neural precursor
markers, immunocytochemical analysis was conducted.
Positive staining of iNP colonies for SOX2, PAX6 and NGN2
confirmed qPCR results at the protein level (Figure 3B).
However, irregular expression patterns were observed in a
small number of colonies which may also suggest partial
reprogramming. Combined, these results demonstrate that
transient expression of SOX2 and PAX6 in human fibroblasts
induce cell colonies that display the transcriptional and
phenotypic signature of neural precursor cells.

Induced neural precursor colonies have the capacity to
differentiate into mature neurons and astrocytes.
To investigate the capacity of iNP colonies to differentiate
into mature neurons and glial cells, we tested several
differentiation conditions. We have previously demonstrated
efficient differentiation of neural precursor cells derived from
the subventricular zone of the adult rat brain using standard
[43,44]
As such, induced neural
neural differentiation media.
P166
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Figure 4: Neuronal and astroglial differentiation of induced neural precursor cells. Co-expression of (A) MASH1 and NGN2 and (B) SOX2 and PAX6 in
differentiating iNP colonies. (C) iNP-derived neurons express the neuronal markers TUJ1, NSE, and MAP2. Arrows indicate cells exhibiting a typical neuronal
morphology. (D) iNP-derived neurons express GAD65/67 or (E) tyrosine hydroxylase (TH) with NSE co-expression. (F) Image of iNP-derived neuron undergoing
patch clamp recording after 30 days of differentiation. (G) Representative trace of action potential generated in response to current injections from iNP-derived
neuron after 30 days of differentiation. (H) Astrocytes derived from iNP cells express the astroglial marker GFAP. Scale bars: 25 µm.

precursor colonies generated by plasmid transfection were
cultured in standard neural differentiation media for two
weeks. Immunocytochemical analysis demonstrated coexpression of the pro-neural markers MASH1 and NGN2
(Figure 4A) and enduring expression of SOX2 and PAX6
(Figure 4B) following two weeks of differentiation. However,
iNP colonies did not differentiate into either neurons or glia
as indicated by a lack of staining for the markers MAP2,
GFAP and RIP, and remained in their colony assemblage.
Several studies suggest the use of sonic hedgehog (SHH) to
efficiently regulate neuronal differentiation of hES-derived
[33,45]
Thus, we examined whether a modified
neurospheres.
two-staged differentiation protocol which has previously been
[33]
demonstrated to generate mature neurons from iPSCs
could drive efficient neuronal differentiation of iNP cells.
Induced neural precursor colonies were mechanically
dissociated and cultured in neural differentiation media
supplemented with SHH, DKK1, BDNF and Y27632 for 10
days. The cells were subsequently exposed to dibutryl-cyclic
AMP, VPA, BDNF and Y27632. After 13 days of
differentiation a proportion of iNP cells developed a neuronlike morphology with tangential and radial processes.
Continued differentiation up to 30 days resulted in an
increase in the proportion of iNP cells exhibiting a typical
neuronal morphology and the generation of a more mature
phenotype with the appearance of multiple arborizing
dendrites and a single axon from the cell soma. Further
confirmation of neuronal differentiation was demonstrated by
robust expression of the neuronal markers TUJ-1, NSE and
MAP2 (Figure 4C). A population of iNP-derived neurons also
expressed the GABAergic marker GAD65/67 (Figure 4D) or the
catecholaminergic marker tyrosine hydroxylase (TH) (Figure
4E). To determine whether iNP-derived neurons exhibit
excitable membrane properties similar to mature neurons,
whole cell patch clamping was performed. Initial recordings

performed after 13 or 21 days of differentiation revealed the
presence of functionally immature cells. The average resting
membrane potentials were depolarized (-39.8 ± 4.3 mV, n =
6 cells and -38.5 ± 3.3 mV, n = 11 cells respectively) and no
action potentials could be evoked by current injection.
However, after 30 days differentiation functionally mature
neurons were able to fire single action potentials upon
current injection (Figures 4F, 4G). Moreover, the average
resting membrane potential had shifted to significantly more
hyperpolarised potentials (-50.8 ± 2.9 mV, n = 15 cells)
compared to recordings performed at days 13 and 21 (p <
0.05). This was accompanied by a significant increase in
membrane capacitance (from 164.5 ± 48.0 pF to 869.3 ±
334.2 pF; p < 0.05) consistent with significant increases in
the amount of neuronal membrane as the cells develop a
more mature neuronal morphology.
To determine the glial differentiation potential of iNP colonies,
we mechanically dissociated iNP cells and cultured them in
astroglial
or
oligodendroglial
differentiation
media,
respectively. We observed a small proportion (< 1%) of cells
expressing the astrocytic marker GFAP and exhibiting an
astrocyte-like morphology after 14 days of differentiation
(Figure 4H). However, no cells were found expressing the
oligodendrocyte markers O4 or RIP when cultured under
oligodendroglial conditions (data not shown).

Discussion
The current study demonstrates a method to directly convert
adult human fibroblasts into neural precursor cells. This was
achieved by exogenous application of the transcription
factors SOX2 and PAX6. In order to avoid genome
interference, non-viral plasmid transfection or protein
transduction techniques were chosen for ectopic expression
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of SOX2 and PAX6. The time period required for fibroblasts
to form iNP colonies was comparable with previous studies
using protein transduction and plasmid transfection to
generate iPSCs, indicating a significant impact of
[46,47]
In contrast,
methodology on the reprogramming process.
the efficiency of iNP colony generation of 0.05% of the initial
transfected/transduced fibroblast cells was considerably
higher than the induction of iPSCs using non-viral
methods.[46,47]
Others have recently demonstrated the direct generation of
[14-17]
neural stem and precursor cells from either embryonic
[18]
or adult
mouse fibroblast cells. This was achieved by viral
transduction of either the four pluripotent transcription factors
[15]
OCT3/4, SOX2, KLF4, and C-MYC in a transient manner ,
or viral transduction of up to eleven neural stem cellassociated factors.[16-18] In two other studies the protooncogene BMI1 was identified as a key factor in
reprogramming mouse fibroblasts into either induced neural
[17,18]
Interestingly, Han and
stem or precursor cells.
[14]
colleagues
observed morphological transformation of
mouse embryonic fibroblasts 2-3 weeks after viral delivery of
SOX2 and PAX6. However, the cells were not analyzed or
cultured to a stage later than 3 weeks post transduction.
Further, a recent study has demonstrated the reprogramming
of mouse embryonic fibroblasts and human fetal foreskin
fibroblasts into multipotent neural stem-like cells following
retroviral transduction of SOX2 when cultured on a mitomycin
[48]
This is the first study to
C-treated MEF feeder layer.
demonstrate the generation of neural stem-like cells from
human fibroblasts and supports the findings presented in the
current study. Using both SOX2 and PAX6, we now extend
these findings to the generation of iNP cells from adult
human fibroblasts by non-viral delivery without the
requirement of a MEF feeder layer.
In the current study, iNP colonies exhibited elevated
expression of the neural stem and pro-neural markers SOX1,
SOX2, PAX6, NGN2, HOXB9 and NKX6.1, with downregulation of HES1 and IRX3 mRNA after SOX2/PAX6
protein delivery or 65 days following plasmid transfection.
Due to the transient nature of both the plasmid transfection
and protein transduction procedures utilized in this study, we
were able to determine the effect of endogenous SOX2 and
PAX6 mRNA expression in the resultant iNP cells.
Interestingly, temporal analysis of mRNA expression
revealed an inverse shift of expression with reduced relative
mRNA levels of PAX6, SOX2, NGN2 and SOX1 and
concurrent elevation of HES1, IRX3, SIX3 expression in
independent colonies analyzed at 75 and 85 days compared
to 65 days following SOX2/PAX6 delivery. PAX6 has
previously been demonstrated to regulate NGN2 expression
in a concentration-dependent manner [49], reflected by the
temporal correlation of PAX6 and NGN2 expression
observed in iNP colonies. Further, down-regulation of the
transcriptional repressor HES1, with opposing functions to
PAX6, is in accordance with PAX6 up-regulation and
[30]
Elevated mRNA
PAX6/HES1 regulation of neurogenesis.
expression of the putative pluripotent markers OCT3/4 and
NANOG was also detected with gradually decreasing levels
in cells from 65 to 75 days following SOX2/PAX6 delivery.
OCT3/4 and NANOG expression in iNP cells was in
agreement with studies demonstrating that SOX2 and OCT3/4 work cooperatively to regulate their own transcription by a
positive feedback loop, and that OCT3/4 and SOX2 in turn

activate NANOG expression.[40,50] Interestingly, 85 days post
SOX2/PAX6 transfection OCT3/4 levels were found to be
increased whereas NANOG and SOX2 expression levels
were decreased compared to 75 days post transfection.
To prove the capacity for iNP cells generated by SOX2/PAX6
delivery to form mature neurons, we tested several
differentiation conditions and assessed the expression of
mature neuronal markers as well as the electrophysiological
properties of differentiated iNP cells. Mature neurons were
able to be derived from iNP colonies by a differentiation
protocol which included SHH and BDNF. Differentiated cells
showed a distinctive neuronal morphology including multiple
arborizing dendrites and expression of the neuronal markers
TUJ1, NSE and MAP2 with a population of iNP-derived
neurons expressing TH or GAD65/67. Most importantly, iNPderived neurons demonstrated the ability to fire action
potentials in response to current injection. Measurement of
the electrical properties of iNP-derived neurons at different
time points during differentiation confirmed a gradual
maturation process over a period of 30 days. In addition, iNP
cells were able to give rise to a small population of astrocytes
as demonstrated by staining for the astrocytic marker GFAP.
However, we were not able to detect oligodendroglial
[16]
also observed a lack
differentiation. Lujan and colleagues
of oligodendrocyte differentiation from neural precursor cells
which were generated from mouse embryonic fibroblasts by
viral delivery of the two transcription factors SOX2 and
FOXG. Oligodendroglial differentiation was only achieved by
addition of BRN2. It would be interesting to further assess
whether a combination of BRN2, PAX6 and Sox2 can also
successfully convert human fibroblasts to iNP cells capable
of oligodendrocyte differentiation.

Conclusion
The current study provides proof-of-concept that transient
expression of the neural transcription factors SOX2 and
PAX6 directly converts adult human fibroblasts into neural
precursor-like cells. The use of either non-viral plasmid
transfection or recombinant protein transduction alleviates
concerns of insertional mutation associated with the use of
genome-integrating viral vectors. Further studies will be
necessary to thoroughly optimize the efficiency for human
iNP cell generation and neural differentiation. Such studies
will facilitate the application of this method for future use for
in vitro disease modeling, drug screening and as a ready
source of human autologous neural precursor cells for cell
replacement therapy.
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